These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 8548832
1. IL-2-resistant hyporesponsiveness induced by CD4 mAbs in OKT3-activated human T cells is reversed by CD45RA triggering. Robinet E, Fournel S, Fatmi A, Revillard JP. Cell Immunol; 1996 Jan 10; 167(1):1-7. PubMed ID: 8548832 [Abstract] [Full Text] [Related]
2. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69. Woods M, Guy R, Waldmann H, Glennie M, Alexander DR. Cell Immunol; 1998 May 01; 185(2):101-13. PubMed ID: 9636688 [Abstract] [Full Text] [Related]
5. Specific hyporesponsiveness of alloreactive peripheral T cells induced by CD4 antibodies. Vincent C, Fournel S, Wijdenes J, Revillard JP. Eur J Immunol; 1995 Mar 01; 25(3):816-22. PubMed ID: 7705413 [Abstract] [Full Text] [Related]
6. Differential activation of p21ras in CD45RA+ and CD45RO+ human T lymphocytes. Patel HR, Renz H, Terada N, Gelfand EW. J Immunol; 1994 Mar 15; 152(6):2830-6. PubMed ID: 8144884 [Abstract] [Full Text] [Related]
8. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations. Zhu HG, Klein-Franke A, Anderer FA. Anticancer Res; 1994 Mar 15; 14(3A):953-61. PubMed ID: 8074498 [Abstract] [Full Text] [Related]
9. Bidirectional modulation of human B cell stimulation by activated T cells. Hirohata S, Shinohara S. Cell Immunol; 1993 Sep 15; 150(2):257-68. PubMed ID: 8370072 [Abstract] [Full Text] [Related]
10. Engagement of the CD4 receptor inhibits the interleukin-2-dependent proliferation of human T cells transformed by Herpesvirus saimiri. Bröker BM, Tsygankov AY, Fickenscher H, Chitaev NA, Müller-Fleckenstein I, Fleckenstein B, Bolen JB, Emmrich F, Schulze-Koops H. Eur J Immunol; 1994 Apr 15; 24(4):843-50. PubMed ID: 8149955 [Abstract] [Full Text] [Related]
11. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse. Chen FL, Kung JT. J Immunol; 1996 Mar 15; 156(6):2036-44. PubMed ID: 8690890 [Abstract] [Full Text] [Related]
15. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes. Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C. Exp Hematol; 2007 Mar 15; 35(3):416-25. PubMed ID: 17309822 [Abstract] [Full Text] [Related]
16. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Chen HW, Liao CH, Ying C, Chang CJ, Lin CM. Clin Immunol; 2006 Apr 15; 119(1):21-31. PubMed ID: 16406844 [Abstract] [Full Text] [Related]
18. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. Levine BL, Bernstein WB, Connors M, Craighead N, Lindsten T, Thompson CB, June CH. J Immunol; 1997 Dec 15; 159(12):5921-30. PubMed ID: 9550389 [Abstract] [Full Text] [Related]
19. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions. Hirohata S. Cell Immunol; 1997 Nov 01; 181(2):182-91. PubMed ID: 9398405 [Abstract] [Full Text] [Related]
20. Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway. Sun Y, Pinchuk LM, Agy MB, Clark EA. J Immunol; 1997 Jan 01; 158(1):512-7. PubMed ID: 8977229 [Abstract] [Full Text] [Related] Page: [Next] [New Search]